THORN RUN PARTNERS

Lobbying for OTSUKA AMERICA PHARMACEUTICAL, INC. · Pharmaceutical manufacturer.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Pharmacy

Pharmaceutical reimbursement issues.

Health Issues

Issues related to neurological treatments.

Taxation/Internal Revenue Code

Corporate tax issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.